All material subject to strictly enforced copyright laws. © 2022 Euromoney Institutional Investor PLC group
SecuritizationCLOs-CDOs

US levloan feels pricing pain, but balance of power intact

Pricing for European companies like Armacell and Altice marketing leveraged loans in the US has soared in the turmoil following the Fed’s signal on tapering QE, writes Olivier Holmey. But while deals in the less ramped up European market were largely unscathed, few bankers expect the setback to change the longer term appeal of either sector — especially with European CLOs under regulatory pressure.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login
We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree